Shadbolt Cade, Abbott J Haxby, Camacho Ximena, Clarke Philip, Lohmander L Stefan, Spelman Tim, Sun Eric C, Thorlund Jonas B, Zhang Yuting, Dowsey Michelle M, Choong Peter F M
Department of Surgery, St. Vincent's Hospital, The University of Melbourne, Melbourne, VIC, Australia.
Centre for Musculoskeletal Outcomes Research, Department of Surgical Sciences, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand.
Front Surg. 2020 Feb 18;7:4. doi: 10.3389/fsurg.2020.00004. eCollection 2020.
Over the past two decades, there has been a sharp rise in the use of prescription opioids. In several countries, most notably the United States, opioid-related harm has been deemed a public health crisis. As surgeons are among the most prolific prescribers of opioids, growing attention is now being paid to the role that opioids play in surgical care. While opioids may sometimes be necessary to provide patients with adequate relief from acute pain after major surgery, the impact of opioids on the quality and safety of surgical care calls for greater scrutiny. This narrative review summarizes the available evidence on rates of persistent postsurgical opioid use and highlights the need to target known risk factors for persistent postoperative use before patients present for surgery. We draw attention to the mounting evidence that preoperative opioid exposure places patients at risk of persistent postoperative use, while also contributing to an increased risk of several other adverse clinical outcomes. By discussing the prevalence of excess opioid prescribing following surgery and highlighting significant variations in prescribing practices between countries, we note that there is a pressing need to optimize postoperative prescribing practices. Guided by the available evidence, we call for specific actions to be taken to address important research gaps and alleviate the harms associated with opioid use among surgical patients.
在过去二十年中,处方阿片类药物的使用急剧增加。在几个国家,尤其是美国,阿片类药物相关危害已被视为一场公共卫生危机。由于外科医生是阿片类药物最主要的开方者之一,如今人们越来越关注阿片类药物在外科护理中所起的作用。虽然有时可能需要使用阿片类药物为接受大手术后的患者提供充分的急性疼痛缓解,但阿片类药物对外科护理质量和安全的影响需要更严格的审查。这篇叙述性综述总结了关于术后持续使用阿片类药物发生率的现有证据,并强调在患者进行手术前针对已知的术后持续使用风险因素采取措施的必要性。我们提请注意越来越多的证据表明,术前接触阿片类药物会使患者面临术后持续使用的风险,同时还会增加其他几种不良临床结局的风险。通过讨论术后阿片类药物过度处方的普遍性,并强调各国处方做法的显著差异,我们指出迫切需要优化术后处方做法。依据现有证据,我们呼吁采取具体行动来填补重要的研究空白,并减轻外科患者中与阿片类药物使用相关的危害。